IMMUNOSCORE IC
LIVE

Serial Number

79342738

Owner

VERACYTE

Attorney

ROSALEEN H. CHOU

Filing Date

Apr 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOSCORE IC Trademark

Serial Number: 79342738 • Registration: 7318047

IMMUNOSCORE IC is a trademark filed by VERACYTE on April 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

VERACYTE (7 trademarks)

PARC SCIENTIFIQUE DE LUMINY

Entity Type: 34

Trademark Details

Filing Date

April 29, 2022

Registration Date

March 5, 2024

Published for Opposition

December 19, 2023

Goods & Services

Downloadable or recorded software for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors; downloadable application software in the field of clinical biology for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors

Pharmaceutical products, namely, pharmaceutical products for use in the treatment of cancer; chemical preparations for medical and pharmaceutical use, namely for use in the treatment of cancer; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for providing information on diagnostics or identification of biological systems for medical use; immunological reagents for medical use; biological reagents for medical diagnosis; diagnostic kits comprising medical diagnostic reagents and medical diagnostic tests for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis

Medical analysis services for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; medical assistance; medical diagnostics and diagnostics in the field of medicine, namely in the fields of immuno-oncology and cancer research; genetic analysis services, namely in the fields of immuno-oncology and cancer research

Research, development, technical design and scientific testing services, namely scientific research for relating to cancer treatment; industrial analysis and research services in the fields of immuno-oncology and cancer research; clinical trial services, namely providing laboratory testing in clinical trials; tests in laboratories, namely in the fields of immuno-oncology and cancer research; development of testing methods for others in the fields of immuno-oncology and cancer research; research, development, technical design, testing, consultancy and analysis services in the field of immuno-oncology; research services in the field of genome and immune index analysis; design and development of software in the field of biology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Dec 19, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 29, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 29, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 22, 2023 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2023 TROA
REFUSAL PROCESSED BY IB
May 10, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 27, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 16, 2022 REPR